2024 ICD-10-CM Diagnosis Code D86.3

Sarcoidosis of skin

ICD-10-CM Code:
ICD-10 Code for:
Sarcoidosis of skin
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Code Navigator:

Code Classification

  • Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
    • Certain disorders involving the immune mechanism
      • Sarcoidosis

D86.3 is a billable diagnosis code used to specify a medical diagnosis of sarcoidosis of skin. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • Acute skin sarcoidosis
  • Annular sarcoidosis
  • Atrophic sarcoidosis
  • Chronic skin sarcoidosis
  • Cutaneous sarcoidosis
  • Hypomelanotic sarcoidosis
  • Ichthyosiform sarcoidosis
  • Lichenoid sarcoidosis
  • Maculopapular sarcoidosis
  • Mass of palm
  • Nail dystrophy due to sarcoidosis
  • Nodule of skin of foot
  • Nodule of skin of head
  • Orofacial sarcoid
  • Palmoplantar sarcoidosis
  • Papular sarcoidosis
  • Post-inflammatory hypopigmentation
  • Postinflammatory skin pigmentation change
  • Sarcoidosis in scar
  • Sarcoidosis, angiolupoid type
  • Sarcoidosis, erythrodermic type
  • Sarcoidosis, lupus pernio type
  • Sarcoidosis, nodular type
  • Sarcoidosis, plaque type
  • Subcutaneous sarcoidosis
  • Ulcerative sarcoidosis
  • Verrucous sarcoidosis

Clinical Classification

Clinical Information

  • Cutaneous Sarcoidosis

    formation of non-necrotizing granulomas in the skin. it may be a manifestation of systemic sarcoidosis or may also arise in isolation.

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Convert D86.3 to ICD-9-CM

  • ICD-9-CM Code: 135 - Sarcoidosis
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Patient Education


Sarcoidosis is a disease that leads to inflammation, usually in your lungs, skin, or lymph nodes. It starts as tiny, grain-like lumps, called granulomas. Sarcoidosis can affect any organ in your body.

No one is sure what causes sarcoidosis. It affects men and women of all ages and races. It occurs mostly in people ages 20 to 50, African Americans, especially women, and people of Northern European origin.

Many people have no symptoms. If you have symptoms, they may include:

  • Cough
  • Shortness of breath
  • Weight loss
  • Night sweats
  • Fatigue

Tests to diagnose sarcoidosis include chest x-rays, lung function tests, and a biopsy. Not everyone who has the disease needs treatment. If you do, prednisone, a type of steroid, is the main treatment.

NIH: National Heart, Lung, and Blood Institute

[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.


[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.